Laura Elizabeth Lansdowne
Managing Editor
As managing editor, Laura works closely with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She plays an active part in the general oversight and training of the in-house editorial team, as well as working directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.
Latest Content
Industry Insight
Simulator Technology Can Predict Optimal Vaccine Dosing
Certara is developing biosimulation and tech-enabled approaches to help scientists answer key questions at various stages of the development pipeline, serving to inform and accelerate the path to regulatory approval. One such approach, the company’s Vaccine Simulator™, can be leveraged across different therapeutic areas to determine optimal vaccine dosing and dosing regimens for different patient cohorts.
News
Treating Hearing Loss: The Hunt for Drugs That Promote Hair Cell Regeneration
A research team from Nanjing University has used cochlear organoids to identify drugs that can promote the regeneration of hair cells. The study, published in Stem Cell Reports, also identifies a signaling pathway as a potential target for hearing restoration.
News
High-Intensity Focused Ultrasound: A Novel Non-Invasive Cancer Treatment
A research team has examined the use of high-intensity focused ultrasound as a non-invasive cancer treatment that works by targeting acoustic waves to destroy cancer cells. The study was published in Bulletin of Mathematical Biology.
Podcast
Opinionated Science Episode 34: Genetics of Endometriosis, the Birthing Brain and Cancer Vaccines
In this episode, the Technology Networks team reviews world-leading research into the mechanisms behind endometriosis, a condition that affects up to 10% of women of reproductive age, but often takes a decade to diagnose. There's also a peek into mom's brain during birth and a new cancer vaccine that harnesses similar technology used to create the Oxford–AstraZeneva COVID-19 vaccine.
News
Nine Existing Drugs Reduce SARS-CoV-2 Viral Load in Cell-Based Study
A new study by researchers at the University of Manchester suggests that existing FDA-approved drugs may be suitable for repurposing as prophylactics, or for use in combination with vaccine therapy, to ward off COVID-19.
Infographic
Tumor Heterogeneity
Cancer is an extremely complex group of diseases. As it progresses, tumors can evolve to comprise varied cell types with distinct morphological and genetic features. This diversity – or heterogeneity – is reflected at many levels. In this infographic, we explore the mechanisms causing intratumor heterogeneity and the clinical implications of cancer heterogeneity.
Article
Stay Up-to-Date With COVID-19 Drug Development
Researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.
Article
Stay Up-to-Date With COVID-19 Vaccine Development
Technology Networks is committed to keeping you updated with the latest research in this space. Here, you'll find a curation of our latest COVID-19 vaccine-related content.
Article
Microphysiological Systems: Approaches, Applications and Opportunities
In this article, we highlight advances in the field that have been instrumental to the development of microphysiological systems, as well as key applications and future opportunities.
News
Caffeine Buzz Boosts Bees’ Ability To Find Specific Blooms
Researchers have demonstrated that by supplying bees with caffeine it is possible to boost their ability to remember the smell of a specific flower. The team’s findings were published in Current Biology, July 28, 2021.
Advertisement
